Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Pediatric Chronic ITP
NCT06073925Phase 1Unknown
- Sponsor
- Mansoura University
- Start
- Dec 2023
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 1, randomised, open-label trial of vitamin d in immune thrombocytopenia (ITP) (3 arms), sponsored by Mansoura University. Primary endpoint: Change in platelet count at 3 months. Status: unknown.
02
Drugs
vitamin d
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT06073925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06073925.